Cargando…

Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer

Small cell lung cancer (SCLC) is an aggressive neuroendocrine carcinoma with a poor prognosis. Initial responses to standard-of-care chemo-immunotherapy are, unfortunately, followed by rapid disease recurrence in most patients. Current treatment options are limited, with no therapies specifically ap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rudin, Charles M., Reck, Martin, Johnson, Melissa L., Blackhall, Fiona, Hann, Christine L., Yang, James Chih-Hsin, Bailis, Julie M., Bebb, Gwyn, Goldrick, Amanda, Umejiego, John, Paz-Ares, Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290806/ https://www.ncbi.nlm.nih.gov/pubmed/37355629 http://dx.doi.org/10.1186/s13045-023-01464-y

Ejemplares similares

DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms
por: Yao, James, et al.
Publicado: (2022)

Divergent functions and distinct localization of the Notch ligands DLL1 and DLL3 in vivo
por: Geffers, Insa, et al.
Publicado: (2007)

DLL3: an emerging target in small cell lung cancer
por: Owen, Dwight H., et al.
Publicado: (2019)

Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer
por: Jubb, A M, et al.
Publicado: (2009)

Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study
por: Paz-Ares, Luis, et al.
Publicado: (2023)

Systematic Literature Review of the Prevalence and Prognostic Value of Delta-Like Ligand 3 Protein Expression in Small Cell Lung Cancer
por: Bylsma, Lauren C., et al.
Publicado: (2023)

Influence of preanalytical variables on performance of delta-like protein 3 (DLL3) predictive immunohistochemistry
por: Radonic, Teodora, et al.
Publicado: (2020)

Context-Dependent Functional Divergence of the Notch Ligands DLL1 and DLL4 In Vivo
por: Preuße, Kristina, et al.
Publicado: (2015)

The Notch ligand Delta-like 4 (DLL4) as a target in angiogenesis-based cancer therapy?
por: Brzozowa, Marlena, et al.
Publicado: (2013)

1703 Delta-like 1 ligand (DLL) measurement in cerebrospinal fluid for detection of Mycobacterium tuberculosis meningitis
por: Bahr, Nathan, et al.
Publicado: (2014)

Distinct expression patterns of Notch ligands, Dll1 and Dll4, in normal and inflamed mice intestine
por: Shimizu, Hiromichi, et al.
Publicado: (2014)

Delta-Like Ligand (DLL)1 Expression in Early Mouse Decidua and Its Localization to Uterine Natural Killer Cells
por: Degaki, Karina Y., et al.
Publicado: (2012)

DLL3 (delta-like protein 3) expression correlates with stromal desmoplasia and lymph node metastases in medullary thyroid carcinomas
por: Ingenwerth, M, et al.
Publicado: (2021)

High Delta-Like Ligand 4 (DLL4) Is Correlated With Peritumoral Brain Edema and Predicts Poor Prognosis in Primary Glioblastoma
por: Qiu, Xian-xin, et al.
Publicado: (2014)

Delta/Notch-Like EGF-Related Receptor (DNER) Is Not a Notch Ligand
por: Greene, Maxwell, et al.
Publicado: (2016)

The ectodomains determine ligand function in vivo and selectivity of DLL1 and DLL4 toward NOTCH1 and NOTCH2 in vitro
por: Tveriakhina, Lena, et al.
Publicado: (2018)

Intraovarian regulation of gonadotropin-dependent folliculogenesis depends on notch receptor signaling pathways not involving Delta-like ligand 4 (Dll4)
por: Jovanovic, Vuk P, et al.
Publicado: (2013)

Spatial patterning of the Notch ligand Dll4 controls endothelial sprouting in vitro
por: Tiemeijer, L. A., et al.
Publicado: (2018)

Delta-like ligand 3–targeted radioimmunotherapy for neuroendocrine prostate cancer
por: Korsen, Joshua A., et al.
Publicado: (2022)

The divergent DSL ligand Dll3 does not activate Notch signaling but cell autonomously attenuates signaling induced by other DSL ligands
por: Ladi, Ena, et al.
Publicado: (2005)

O-fucosylation of the Notch Ligand mDLL1 by POFUT1 Is Dispensable for Ligand Function
por: Müller, Julia, et al.
Publicado: (2014)

IL-18–secreting CAR T cells targeting DLL3 are highly effective in small cell lung cancer models
por: Jaspers, Janneke E., et al.
Publicado: (2023)

Endothelial Delta-like 4 (DLL4) promotes renal cell carcinoma hematogenous metastasis
por: Huang, Qing Bo, et al.
Publicado: (2014)

Synthesis and Comparative In Vivo Evaluation of Site-Specifically Labeled Radioimmunoconjugates for DLL3-Targeted ImmunoPET
por: Sharma, Sai Kiran, et al.
Publicado: (2021)

The Notch ligand DLL1 exerts carcinogenic features in human breast cancer cells
por: Sales-Dias, Joana, et al.
Publicado: (2019)

Activity of the mouse Notch ligand DLL1 is sensitive to C-terminal tagging in vivo
por: Schuster-Gossler, Karin, et al.
Publicado: (2021)

A Case of Bowen’s Disease and Small-Cell Lung Carcinoma: Long-Term Consequences of Chronic Arsenic Exposure in Chinese Traditional Medicine
por: Lee, Linda, et al.
Publicado: (2005)

The emerging role of nimotuzumab in the treatment of non-small cell lung cancer
por: Boland, William, et al.
Publicado: (2010)

O-Fucosylation of DLL3 Is Required for Its Function during Somitogenesis
por: Serth, Katrin, et al.
Publicado: (2015)

DLL3 regulates Notch signaling in small cell lung cancer
por: Kim, Jun W., et al.
Publicado: (2022)

Bone Marrow-Derived Endothelial Progenitors Expressing Delta-Like 4 (Dll4) Regulate Tumor Angiogenesis
por: Real, Carla, et al.
Publicado: (2011)

Dll1 Can Function as a Ligand of Notch1 and Notch2 in the Thymic Epithelium
por: Hirano, Ken-ichi, et al.
Publicado: (2022)

Rovalpituzumab Tesirine: A Novel DLL3-Targeting Antibody–Drug Conjugate
por: Lashari, Bilal H., et al.
Publicado: (2018)

Near infrared photoimmunotherapy targeting DLL3 for small cell lung cancer
por: Isobe, Yoshitaka, et al.
Publicado: (2020)

Expressions and Prognostic Values of Notch3 and DLL4 in Human Breast Cancer
por: Wang, Lin, et al.
Publicado: (2023)

Harnessing DLL3 inhibition: From old promises to new therapeutic horizons
por: Cortinovis, Diego Luigi, et al.
Publicado: (2022)

Identification of DLL3-related genes affecting the prognosis of patients with colon adenocarcinoma
por: Xiang, Jinyu, et al.
Publicado: (2023)

Dll4–Notch signaling in Flt3-independent dendritic cell development and autoimmunity in mice
por: Billiard, Fabienne, et al.
Publicado: (2012)

Characterization of Two Distinct Lymphoproliferative Diseases Caused by Ectopic Expression of the Notch Ligand DLL4 on T Cells
por: Xiong, Huizhong, et al.
Publicado: (2013)

Gamma-Secretase Inhibitor, DAPT, Prevents the Development of Retinopathy of Prematurity in a Rat Model by Regulating the Delta-Like Ligand 4/Notch Homolog-1 (DLL4/Notch-1) Pathway
por: Sun, Wei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2rdflh9kc1igscjrtitv1290c7